Our comprehensive Epilepsy Program delivers world-class care for epilepsy patients with state-of-the-art techniques and treatment approaches. U of U Health is one of only a few medical centers in the ...

New Guardant Reveal offering provides oncologists with tissue-free solution to monitor treatment response and detect early disease progression with unprecedented speed and sensitivity Reveal is ...

Scientists have discovered a novel low-cost method of testing for cancers. Called the Heatrich-BS assay, this new test sequences clinical samples that have been heated in order to isolate ...

AIIMS Delhi has resumed free Therapeutic Drug Monitoring (TDM) tests for epilepsy patients. This initiative reduces financial ...

Delfi Diagnostics has put forward a new cancer monitoring test that searches the blood for broken pieces of tumor DNA, and it is kicking off the test’s launch with a collaboration with Immunocore to ...

“HPV DNA testing is proven to be more effective in detecting precancerous changes of the cervix compared to conventional pap ...

A new development in wireless sensing technology that can reliably screen for five common pulmonary diseases could lead to ...

Revvity launches its first set of IVD Mimix reference standards, providing diagnostic labs with trusted quality controls for optimizing tests and monitoring workflows “Accurate diagnosis, including ...

Wilmington, Del.-based ChristianaCare developed a new virtual telehealth service that offers daily monitoring of employees for COVID-19 symptoms and testing for employers and businesses. As of June 8, ...

Please provide your email address to receive an email when new articles are posted on . Stanford University nephrologist Vivek Bhalla, MD, FASN, FAHA, understands the value of more aggressive ...

Three at-home vision-monitoring tools failed to detect worsening neovascular age-related macular degeneration (AMD), a diagnostic-test accuracy study reported. The paper-based KeepSight Journal from ...

The All India Institute of Medical Sciences has introduced a free therapeutic drug monitoring test for patients with epilepsy ...